4-amino-N-(1-((3,4-dichlorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide | 1446111-81-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 4-amino-N-(1-((3,4-dichlorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide
• 英文别名: 4-amino-N-[1-(3,4-dichloroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide
• CAS: 1446111-81-4
• 化学式: C₂₃H₁₆Cl₂N₆OS
• 分子量: 495.392
• InChiKey: IQLYOMSTQATNLD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  33
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.04
• 拓扑面积：
  134
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• [EN] THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES<br/>[FR] DÉRIVÉS THIÉNO[3,2-D]PYRIMIDINES AYANT UNE ACTIVITÉ INHIBITRICE POUR DES PROTÉINES KINASES
  申请人：HANMI PHARM IND CO LTD

  公开号：WO2013100632A1

  公开（公告）日：2013-07-04

  Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

  提供一种具有蛋白激酶抑制活性的噻吩[3,2-d]嘧啶衍生物（化学式（I））或其药用可接受的盐，以及包含该衍生物的药物组合物，用于预防和治疗异常细胞生长疾病。
• THIENO[3,2-D]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
  申请人：HANMI PHARM. CO., LTD

  公开号：US20140371219A1

  公开（公告）日：2014-12-18

  Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

  提供一种具有蛋白激酶抑制活性的噻吩[3,2-d]嘧啶衍生物的化学式(I)或其药用可接受盐，以及包含该化合物的药物组合物，用于预防和治疗异常细胞生长疾病。
• PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
  申请人：FLATLEY DISCOVERY LAB

  公开号：US20140371225A1

  公开（公告）日：2014-12-18

  The invention relates to a compound of Formula I and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to a patient in need thereof:

  本发明涉及一种I式化合物及其治疗囊性纤维化方法，包括向需要治疗的患者给予I式化合物的治疗有效剂量。
• Pyridazinone compounds and methods for the treatment of cystic fibrosis
  申请人：Flatley Discovery Lab, LLC

  公开号：US10370366B2

  公开（公告）日：2019-08-06

  The invention relates to a compound of having the following formulae and methods of treating cystic fibrosis:

  本发明涉及一种具有下式的化合物和治疗囊性纤维化的方法：
• THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
  申请人：Hanmi Pharm. Co., Ltd.

  公开号：EP2797927B1

  公开（公告）日：2019-09-25